Author:
Brandes Alba A.,Stupp Roger,Hau Peter,Lacombe Denis,Gorlia Thierry,Tosoni Alicia,Mirimanoff Renè O.,Kros Johan M.,van den Bent Martin J.
Reference11 articles.
1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005
2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009
3. Reardon DA, Friedman AH, Yung WK, et al. A phase I/II trial of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor, in combination with either temozolomide or lomustine for patients with recurrent glioblastoma multiforme (GBM). In: ASCO annual meeting; 2004. p. 1513.
4. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro;Abdollahi;Cancer Res,2003
5. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation;Gorski;Cancer Res,1999
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献